Recent studies indicate a key role of aquaporin (AQP) 4 in astrocyte swelling and brain edema and suggest that AQP4 inhibition may be a new therapeutic way for reducing cerebral water accumulation. To understand the physiological role of AQP4-mediated astroglial swelling, we used 21-nucleotide small interfering RNA duplexes (siRNA) to specifically suppress AQP4 expression in astrocyte primary cultures. Semiquantitative RT-PCR experiments and Western blot analysis showed that AQP4 silencing determined a progressive and parallel reduction in AQP4 mRNA and protein. AQP4 gene suppression determined the appearance of a new morphological cell phenotype associated with a strong reduction in cell growth. Water transport measurements showed that the rate of shrinkage of AQP4 knockdown astrocytes was one-half of that of controls. Finally, cDNA microarray analysis revealed that the gene expression pattern perturbed by AQP4 gene silencing concerned ischemia-related genes, such as GLUT1 and hexokinase. Taken together, these results indicate that 1) AQP4 seems to be the major factor responsible for the fast water transport of cultured astrocytes; 2) as in skeletal muscle, AQP4 is a protein involved in cell plasticity; 3) AQP4 alteration may be a primary factor in ischemiainduced cerebral edema; and 4) RNA interference could be a new potent tool for studying AQP pathophysiology in those organs and tissues where they are expressed.
pressure, which impairs vascular perfusion and can lead to brain ischemia and death. The magnitude of cerebral edema and its clinical symptoms are proportional to the quantity of water retained (2) . Astrocytes play a crucial role in both physiological and pathological conditions. It is well known that astrocytes are involved in regulating water and ion homeostasis to ensure an appropriate neuronal environment (3) . Astrocyte swelling is a common phenomenon occurring in both normal neuronal activity as well as in disease and neuronal necrosis. In particular, swelling of astrocytes, as a consequence of K + accumulation during normal neuronal activity, determines the activation of Cl -channels (4), as well as signal transduction processes that involve a Ca + -dependent activation of the MAP kinases Erk-1 and Erk-2 (5). Moreover, a characteristic swelling of astrocytic foot processes is frequently associated with brain injuries (6, 7, 8) .
In previous works, we demonstrated that brain astrocytes express one of the members of the aquaporin (AQP) family (9, 10) , namely AQP4 (11, 12, 13) . Immunocytochemical studies revealed that AQP4 is expressed at the plasma membrane of astrocytic endfeet surrounding brain vessels and processes extending to the glia limitants. AQP4 is also expressed by the ependymal cells lining the ventricular wall (11, 12) . The particular AQP4 distribution suggested that this protein might be involved in cerebrospinal fluid production as well as in water and volume homeostasis between blood and cerebrospinal fluid. Furthermore, recent studies have demonstrated a key role of AQP4 in brain edema formation and resolution (14, 15, 16, 17) , indicating that pharmacological inhibition of AQP4 activity is a potential new tool for treating brain pathologies associated with edema.
Although many studies have been conducted on the involvement of the AQP4 in brain edema, its physiological and pathophysiological role in brain astrocytes needs to be elucidated.
Immunogold evidence indicates that AQP4 localization is spatially coupled to potassium channel Kir4.1 in retinal Muller cells (18, 19) , suggesting that the function of AQP4 might be related to K + spatial buffering. AQP4 may also be involved in the development and integrity of the bloodbrain barrier (BBB; ref 13) . Furthermore, considering the expression of AQP4 in a number of brain regions associated with vasopressin secretion and thirst, a role of AQP4 in the mechanism of central osmoreception has been proposed (20) .
We have reported (21) that primary astrocyte cultures spontaneously retain the functional expression of AQP4 protein in the plasma membrane and thus represent a valid cell model for studying the role of this AQP in water homeostasis. Although astrocyte primary cultures are a unique cell system for studying the physiological role of AQP4 in the brain, the lack of an inhibitor impedes its full analysis. In fact, mercurial agents cannot be used to inhibit the activity of AQP4 since this water channel is insensitive to them (22, 23) , hence the former name mercurial insensitive water channel (MIWC).
To examine what effect the inhibition of AQP4 expression has in astrocytes, we set up an RNA interference (RNAi) protocol to induce a post-transcriptional AQP4 gene silencing. RNAi is a highly efficient and conserved gene silencing mechanism, triggered by double-stranded RNA (dsRNA), which causes the degradation of homologous RNA (24, 25) . This mechanism, identified in plants (26) , fungi (27) , and animals (28) , is a new alternative method used to determine mammalian gene functions. Since its discovery, RNAi is now being used to induce protein knockdowns in cultured mammalian cells (25, 29) .
In this study, we generated a 21 bp dsRNA oligonucleotide to specifically suppress the expression of AQP4 in order to analyze its functional role in astrocytes. Moreover, cDNA microarrays were used to determine changes in the expression profile of genes from AQP4 silenced astrocytes.
MATERIALS AND METHODS

Astrocyte primary cultures
Astrocytes were prepared from primary cell cultures of neocortical tissues from 3-4 day old rats as described previously (21) following the McCarthy and de Vellis (30) protocol. Briefly, dissected neocortical tissues were minced by passage through a stainless steel mesh; incubated with 0.25% trypsin, 0.01% DNase in DMEM, 100 U/ml penicillin, 100 mg/ml streptomycin, 10% fetal bovine serum (FBS) (medium A); and maintained at 37°C in a 5% CO 2 incubator. After 7-10 days in culture, the flasks were shaken at 200 rpm for 18 h at 37°C. After removal of microglia and oligodendrocytes, astrocytes were trypsinized, resuspended in medium A, and plated in poly-L-lysine coated flasks at a density of 3 × 10 4 cells/cm 2 or 6 × 10 4 cells/cm 2 to be used the day after for gene silencing experiments. The purity of the cell culture was assessed by staining with glial fibrillary acidic protein (GFAP; ref 31). More than 95% of the cells were GFAP positive.
siRNA synthesis
RNA duplexes of 21 nucleotides specific for human AQP1 and rat AQP4 sequences were chemically synthesized by Dharmacon Research, Inc. (Lafayette, CO). AQP1 siRNA was used as CTRL siRNA. From the open reading frame of AQP1 and AQP4 mRNA sequences, duplexes of the type AA(N 19 )UU were designed in order to obtain a 21-nt sense and 21-nt antisense strand with symmetric 2-nt 3′ overhangs of identical sequence (25) . AQP1 sense sequence was AAUGACCUGGCUGAUGGUGUG. AQP4 sense sequence was AAGAUCAGCAUCGCCAAGUCU. AQP4 siRNA sequence corresponded to bp 325-345 of the cDNA rat sequence (22) . Thus, this siRNA interfered with the production of the two AQP4 protein isoforms (22, 23) . The selected siRNA sequences were submitted to a BLAST search to avoid the targeting of other homologous genes.
Transfection of siRNA duplexes
Astrocytes were seeded the day before transfection using an appropriate medium with 10% FBS without antibiotics. Transient transfection of siRNAs was carried out using Oligofectamine ® (Invitrogen, Carlsbad, CA), as suggested by the instructions of the manufacturer. Briefly, the appropriate amount of Oligofectamine was diluted 1:5 in OPTIMEM ® medium (Invitrogen) and incubated at room temperature for 10 min. In parallel, siRNAs were diluted 1:9 in OPTIMEM medium. The two mixtures were combined and incubated for 20 min at room temperature for complex formation. After addition of the appropriate growth medium with 10% FCS and without antibiotics, the entire mixture was added to the cells. Specific silencing was confirmed by at least three independent Western blot and RT-PCR experiments.
Western blotting
To test the efficiency of RNA duplexes, transfected astrocytes were washed once in ice-cold PBS, solubilized in Laemmli buffer, and heated at 37°C for 10 min. Equal amounts of total proteins were separated on 13% polyacrilamide gels. SDS-polyacrilamide gel electrophoresis (SDS-PAGE) was performed as described previously (21) . Membranes with blotted proteins were incubated with rabbit serum anti-AQP4 (11) diluted 1:1000 and with monoclonal anti-GFAP antibodies (Sigma-Aldrich, Srl, Italy) diluted 1:500. After being washed, membranes were incubated with alkaline phosphatase-conjugated secondary antibodies (Sigma), washed again and processed for measuring enzyme activity by using 5-bromo-4-chloro-3-indol-phosphate/nitroblue tetrazolium substrate. AQP4 bands were scanned and intensity was quantified as arbitrary optical density (O.D.) units with the Scion Image System (based on NHI V1.62 Image). AQP4 protein levels of CTRL siRNA and of AQP4 siRNA treated cells were normalized with untreated astrocytes (CTRL). The statistical analysis was conducted by the Student's t test for unpaired data.
Semiquantitative RT-PCR
Total RNA was extracted from cultured astrocytes using the Qiagen RNeasy mini kit (Quiagen) following the instructions of the manufacturer. cDNAs were prepared from 2 µg of total RNA using M-MLV reverse transcriptase (Superscript II, Invitrogen) and random primers. The cDNAs were used to amplify, by PCR, a 410 bp fragment using AQP4 specific primers (forward: 5′-ATCAGCGGTGGCCACATCAA-3′ and reverse: 5′-GATGGGCCCAACCCAATATAT-3′). The relative amounts of AQP4 transcript were estimated by direct comparison between multiple samples after standardization with co-amplification of a 324 bp fragment of 18S rRNA (QuantumRNA kit, Ambion). For quantification, the PCR products were subjected to electrophoresis in a 1.5% agarose gel and stained with ethidium bromide. Photographs were taken with a Polaroid camera and the positive films scanned. Densitometric analysis was performed as described for Western blot and the data presented as the AQP4/18S rRNA ratio.
Immunofluorescence
Astrocytes grown on glass coverslips were fixed and permeabilized with 100% ice-cold methanol for 5 min. After being blocked with 1% gelatin in PBS, cells were incubated for 1 h at room temperature with anti-AQP4 affinity purified antibodies (21) diluted 1:10 together with anti-GFAP antibodies (Sigma) diluted 1:500. After 3 × 5 min washings with PBS-gelatin, sections were incubated with CY3-coupled goat anti-rabbit and FITC-coupled goat anti-mouse antibodies diluted in PBS-gelatin 1:200 and 1:50 respectively (both from Sigma). Sections were examined with a Leica DMRXA photomicroscope equipped for epifluorescence, and digital images were obtained with a cooled CCD camera (Princeton Instruments, NY).
Morphology
Astrocytes in culture were transfected with AQP4 and CTRL RNA duplexes and photographed during gene silencing. For each condition, twenty different zones were randomly chosen and photographed every 24 h for 6 days using a digital photocamera (Nikon Coolpix 5000) connected to a phase-contrast microscope (Nikon Eclipse TE200).
Stopped flow light scattering
Experiments were performed with a stopped-flow spectrophotometer (SFM20, Biologic, Claix, France) characterized by a dead time of 1.6 ms and a maximal rate of data acquisition of 10 kHz. The light of a 150 W mercury-xenon arc lamp was driven from the monochromator to the observation chamber by an optical fiber. Astrocytes from a 75 cm 2 flask were washed and suspended in PBS at a final concentration of 2 × 10 6 cells/ml. Fifty microliters of the cell suspension were mixed in 2 msec with an equal volume of PBS containing 500 mM sucrose to give a 250 mM inwardly directed osmotic gradient. The osmotic gradient caused water efflux, cell shrinkage, and an increase in light scattering. The time course of scattered light intensity at 530 nm was recorded. The data obtained from 5 to 10 determinations were averaged and fitted to single exponential curves using a software provided by Biologic (Claix, France). The fitting parameters were used to calculate the initial rate constant k (s -1 ), and the P f (cm/s -1 ) was determined according to the following equation
where V w is the partial molar volume of water (18 cm 3 /mol), S/V is the ratio of the cell surface area to the initial volume and ∆osm is the osmotic difference between the initial intra-and extracellular sucrose concentration.
Microarray analysis
cDNA microarray expression analysis was performed according to the Affymetrix expression analysis technical manual (Affymetrix GeneChip ® Expression Analysis Manual, P/N 700217 to 700222, Affymetrix, Santa Clara, CA). Total RNA was extracted from cultured astrocytes using the RNeasy mini kit (Qiagen) following the instructions of the manufacturer. Double-stranded cDNA was synthesized from 10 µg of total RNA using the Custom SuperScript Double-stranded cDNA Synthesis Kit ® (Invitrogen) and a T7-(dT) 24 primer (Geneset). Double-stranded cDNA was purified with a phenol/chloroform extraction followed by ethanol precipitation. An in vitro transcription with Essential Enzo Kit ® (Bioarray High Yield RNA Transcription Kit) was performed to produce biotin-labeled cRNA from the cDNA. The amount of product was quantified by spectrophotometric analysis, and the quality of the cRNA was assessed by gel electrophoresis. cRNA was then incubated at 94°C for 35 min in a fragmentation buffer (200 mM Tris-acetate pH 8.1, 500 mM KOAc, 150 mM MgOAc) to produce a distribution of RNA fragment sizes from ~35 to 200 bp. cRNA quality was verified on a test array (TEST3 chip) and then hybridized to Neurobiology U34 chip arrays (Affymetrix), which contain 1200 relevant sequences. The hybridization was performed at the Biopolo core service (Milan, Italy). Briefly, the cocktail, containing the cRNA sample, BSA, and herring sperm DNA, was incubated at 99°C, transferred to 45°C, and then injected into the microarray chamber (Affymetrix). Hybridization was performed automatically in a chamber at 45°C for 16 h while being rotated at 60 rpm. The hybridized probe array was then automatically washed, dried, and scanned twice at an excitation wavelength of 488 nm.
Total RNA prepared from five conditions was analyzed: one of untreated astrocytes (CTRL), two independent conditions of astrocytes treated with the control siRNA (CTRL siRNA), and two independent conditions of astrocytes treated with the AQP4 specific siRNA (AQP4 siRNA).
Each gene on the array was assessed using between 11-20 probe pairs. Each probe pair consists of an oligomer (25 base long) that is designed to be perfectly complementary to a particular message (called the perfect match or PM) and a companion oligomer that is identical to the PM probe except for a single base difference in a central position (called the mismatch or MM probe). The mismatch probe serves as a control for hybridization specificity and helps subtract nonspecific hybridization.
Microarray data analysis
The Affymetrix Genechip software MAS 5.0 (Affymetrix) was used first to collect and process the original expression data from the five rat Affymetrix arrays. The comparative analysis was performed starting from the raw intensity data. Intensity values were normalized on each chip bringing the median to 1 and each gene value of AQP4-siRNA and CTRL-siRNA was compared with that of CTRL to obtain the ratio. As a first step in the analysis, probesets that, at least in one condition of CTRL-siRNA, did not show a high variation compared with CTRL (ratio<|3|) were chosen. Among these, probesets that, at least in one condition of AQP4-siRNA, showed high variation compared with CTRL, were selected. In particular, two different levels of stringency were used: ratio > |3| (low stringency) and ratio > |5| (high stringency).
RESULTS
AQP4 inhibition by RNA interference in astrocyte primary cultures: monitoring of AQP4 mRNA and protein expression levels during AQP4 knockdown experiments
We previously reported that astrocyte primary cultures maintain a high expression level of functional AQP4 water channels, representing an ideal cell model to study the function of AQP4 in the brain (21) . Here, we used RNA interference technology to inhibit AQP4 expression in astrocytes and to obtain informations on its physiological role. Preliminary experiments, performed using different concentrations of siRNA (25, 100, and 600 nM) and two different astrocyte densities (3x10 4 and 6x10 4 cells/cm 2 ), indicated that the optimal concentration of siRNA was 100 nM, while the initial cell density did not seem to have significant effects on gene silencing efficiency (data not shown). We then tested AQP4 protein levels at 2, 4 and 6 days after inducing RNAi by a single initial (day 0) treatment (Fig. 1A) . A control siRNA, corresponding to a siRNA fragment homologous to another AQP, AQP1, not expressed in astrocyte primary cultures or in brain astrocytes, was used in parallel to test the potential non-specific effects of the short RNA duplexes. AQP4 gene silencing was documented by Western blot and semiquantitative RT-PCR and quantified by densitometry analysis. The results show that AQP4 protein levels were progressively reduced by RNAi and reached maximal inhibition (77.9±2.2%) after 6 days. AQP4 protein expression levels were unaffected in control siRNA treated compared with untreated cells, demonstrating the specificity of the results and the lack of toxic effect on the part of the lipid formulation and of the RNA duplexes.
The levels of AQP4 mRNA were analyzed by semiquantitative RT-PCR. Figure 1B shows that AQP4 RNAi determined a significant and progressive decrease in AQP4 mRNA. The maximal effect was observed after 6 days with mRNA levels reduced by 75.6%.
Taken together, these results indicate that AQP4 protein is progressively reduced by RNAi as a consequence of a posttranscriptional siRNA-mediated degradation of AQP4 mRNA.
Water transport measurements in normal and AQP4-knockdown astrocytes
Primary astrocyte cultures display fast water transport associated with high levels of AQP4 expression (21) . In the present study, we used a stopped-flow light scattering method to examine the osmotic water permeability of AQP4-knockdown (KD) astrocytes. Figure 1C shows the time course of scattered light intensity in response to a 250 mOsm inwardly sucrose gradient. The osmotic gradient causes water efflux, astrocyte shrinkage and an increase in scattered light intensity. By calculating the rate constant of shrinkage and the diameter of the astrocyte suspension, P f was estimated to be 0.01 cm/s ± 0.002 (n=3) for CTRL siRNA treated cells (the same value was obtained for untreated cells, data not shown) and 0.005 cm/s ± 0.001 (n=3) for AQP4-KD astrocytes. These results show that AQP4 gene silencing induces alteration in the water transport properties of the astrocyte plasma membrane. P f reduction, as a consequence of AQP4 inhibition, represents the first direct evidence that the high water permeability of astrocytes is AQP4 mediated.
Morphological analysis of astrocytes during AQP4 gene silencing
To determine the possible appearance of a cell phenotype associated with AQP4 gene silencing, a phase contrast microscopy analysis on living cells was performed. CTRL and AQP4 siRNA treated cells were observed daily during AQP4-KD. Figure 2 shows that the day of transfection (day 0), no major differences were observed in terms of the number and morphology of the astrocytes, mostly represented by flat and polygonal shaped cells; at day 2, AQP4 RNAi determined the appearance of a particular cell phenotype characterized by thin elongated astrocytes. Cell growth in the different cultures was largely comparable. At day 4, the morphology of the AQP4-KD astrocytes was extremely different compared with the control. CTRL astrocytes, still characterized by polygonal shaped cells, were growing normally. In contrast, AQP4 RNAi treatment determined a transformation of some elongated astrocytes into process-bearing stellate cells and a visible reduction in cell growth. From days 4 to 6, AQP4 gene silencing determined a further transformation of elongated astrocytes into star-shaped cells with numerous thin and branched processes. When gene silencing came to an end, AQP4-KD astrocyte cultures were characterized almost totally by stellate astrocytes, which normally represent <10% in control cultures (data not shown). Moreover, cell counts at day 6 revealed that the number of total cells in AQP4-KD astrocytes had reduced by 67.9 ± 3.7% (P<0.001, n=4) compared with the CTRL siRNA treated controls. These results clearly demonstrate that knockdown of AQP4 gene causes the appearance of a phenotype that can be easily monitored in live cells by microscopy.
Immunofluorescence analysis of AQP4 expression during AQP4 RNA interference
To correlate AQP4 localization and expression levels together with changes in astrocyte morphology, double immunostaining experiments were performed. AQP4 expression was analyzed together with the astrocyte marker GFAP. Control siRNA-treated astrocytes (Fig. 3 ) strongly expressed AQP4, and no differences in AQP4 expression levels and distribution were found at low (day 2) and high (day 6) cell confluency. Moreover, no major differences in AQP4 staining were found between CTRL RNAi treated and untreated astrocytes (data not shown). At day 2, immunofluorescence analysis of AQP4 siRNA-treated astrocytes revealed the presence of both GFAP-positive elongated and stellate cells. In these two cell types, AQP4 staining appeared to be clearly reduced, and in many cells the AQP4 immunofluorescence signal appeared to be mainly intracellular. From days 4 to 6, the intensity of GFAP staining appeared to be unaffected, although dramatic morphological changes occurred. The AQP4 immunostaining signal progressively reduced, and, at day 6, only a weak signal was detected in the perinuclear region of stellate astrocytes.
Microarray analysis of differential gene expression in AQP4 siRNA treated astrocytes
Gene expression microarray analysis (Affymetrix) was used in order to compare the gene expression profile of control astrocytes with AQP4 silenced astrocytes. We used a rat neurobiology array (U34) containing over 800 known gene sequences relevant to the study of neurobiology. Approximately 400 genes were present on the probes of untreated astrocytes (CTRL) and astrocytes treated with the control siRNA (CTRL siRNA) and with the AQP4 specific siRNA (AQP4 siRNA). Bioinformatic analysis performed with a low level of stringency (ratio>|3|) revealed the presence of 24 altered genes (Fig. 4A ) in AQP4 siRNA astrocytes compared with CTRL. At higher stringency (ratio>|5|), the number of altered genes reduced to 5 (Fig. 4B ). Of these, glucose transporter (GLUT1), hexokinase, and metallothionein-1 were downregulated while NGFI-B (immediate early gene transcription factor induced by NGF) and cfos were upregulated (Table 1) . Although NGFI-B and c-fos also increased in astrocytes treated with CTRL siRNA compared with CTRL, this alteration was considered significant by the criteria used for the bioinformatic analysis (see Methods). It is interesting to note that all these genes, and in particular GLUT1, are involved in ischemia-induced brain edema.
DISCUSSION
In this paper, we have demonstrated that AQP4 expression in astrocyte primary cultures can be efficiently inhibited using RNA interference technology, a new approach very recently applied to mammalian cell culture in order to determine the silencing of a gene of interest and thus to analyze its function (25) .
Knockdown of AQP4 in astrocyte primary cultures results in impaired cell growth, altered cell morphology, and a drastic reduction in membrane water permeability. Changes in astrocyte morphology are already clearly visible after 2 days of treatment. These changes involved the transformation of astrocyte from a classical polygonal into an elongated/fibrous-like shape at the beginning and then into a stellate astrocyte. Cell processes become thinner and longer and the soma smaller compared with control RNAi-treated astrocytes. The morphological changes observed could be interpreted as a cell strategy to increase the surface to volume ratio and hence increase water flux in the absence of AQP4 water channels. Furthermore, AQP4 inhibition has a dramatic effect on cell growth, resulting in a ~68% reduction in cells compared with the control at 6 days of treatment. These modifications suggest that cultured astrocytes require the functional expression of AQP4 to maintain the classical cell morphology and sustain optimal cell growth. It would be interesting to perform similar experiments using astrocytes from AQP4 null mice (32) to determine whether compensatory mechanisms may have been activated.
Evidence for the structural plasticity of astrocytes in the adult central nervous system has been extensively reported (31, 33, 34, 35) . It has been suggested that modifications in astrocyte morphology in vivo may affect neuronal excitability and/or synaptic activity by changing the volume of the extracellular space (36) (37) . Our data indicate that AQP4 is necessary for sustaining astrocyte cell morphology and that water channel activity and cell morphology are both strictly coupled to AQP4 function. This suggests a new functional role of AQP4 in astrocyte plasticity in vivo and further supports our hypothesis that this AQP may be involved in cell plasticity phenomena (38) . In fact, AQP4 is involved in similar phenotypic transformations in skeletal muscle. We have demonstrated that during muscle use/disuse, change from slow oxidative to fast glycolytic fibers is linked to the presence of AQP4 in the sarcolemma. AQP4 involvement in the fast-type transformation of slow fibers suggests its that functional role is linked to the glycolytic pathway and possibly to muscle fatigue (38) .
The morphological switch observed in astrocyte primary cultures when treated with AQP4 siRNA resembles the stellation process occurring when astrocytes are treated with a permeable cAMP analog (39) or by β-adrenergic stimulation (40), although in the latter case the process occurs more rapidly (within 2 h; ref 41) . Interestingly, GFAP, the major component of the intermediate filaments, seems not to be involved in such morphological changes because stellation can occur in GFAP-knockout mice (42) . Similarly, in the present study, we observed that GFAP expression levels were not altered during AQP4 gene silencing, suggesting that similar cytoskeletal alterations could be involved in the astrocyte stellation process occurring when AQP4 is inhibited.
Considering the broad effect that AQP4 inhibition has on astrocyte morphology, cDNA microarray experiments were performed to analyze large-scale gene expression profiles and identify gene expression patterns perturbed by AQP4 gene silencing.
AQP4 gene silencing determines the upregulation of two genes, NGFI-B and c-fos, both members of the immediately early gene family (IEGs) encoding transcription factors, also induced by ischemia (43) . Nerve growth factor inducible protein B (NGFI-B; refs 44, 45 ) is a member of the zinc finger gene belonging to the thyroid/steroid hormone receptor family and is thought to regulate the expression of other genes leading to phenotypic changes (46) , to respond to potassium-induced membrane depolarization (47) and seizure (48) , and to participate in apoptosis (49, 50) . The transcription factor c-fos is induced by a variety of physiological and pathological stimuli, including hypoxia and ischemia (51, 52, 53, 54) . Furthermore, c-fos and NGFI-B are considered markers of functional activation in stress-related neuroendocrine circuitry (52).
Interestingly, the three genes (GLUT1, hexokinase, and metallothionein-1) that were downregulated as a consequence of AQP4 gene silencing have been demonstrated to be directly involved in cerebral ischemia. It is well established that hypoxia, which plays a central role in the pathogenesis of edema, causes a rapid switch from oxidative phosphorylation to anaerobic glycolysis in order to maintain the energy charge of the cell in the brain (55, 56, 57, 58, 59) . In particular, upregulation of glucose transporter (GLUT1) and glycolytic enzymes such as hexokinase, during brain hypoxia, is interpreted as a mechanism to increase both the glucose uptake from the blood to the astrocytes and the glycolytic metabolism (55) . Upregulation of Metallothionein-1, which is a metal binding protein involved in cellular defense against zinc toxicity and free radicals, seems to have a protective role in cerebral ischemia (60, 61) .
It is believed that astrocytes represent the major cell type showing swelling after ischemia (7) . Previous reports have demonstrated that astrocyte AQP4 expression too is upregulated in edema induced by focal brain ischemia (17) , hyponatremia (15) , and in response to brain injuries and edematous tumors (62) . Furthermore, the presence of brain edema has been found in situations in which AQP4 membrane targeting (63, 64) and expression (65) were altered. Our data show that AQP4 gene silencing causes the downregulation of ischemia-affected genes. The importance of these findings is that our experimental model is devoid of pathological elements present in all the studies on brain edema. BBB alterations, neuronal necrosis, and alteration of the homeostatic mechanism in fact make it difficult to understand exactly if AQP4 upregulation is a response contributing to brain edema or whether it is a secondary phenomenon. Although the experimental design does not address the role of AQP4 in brain ischemia, our results suggest that AQP4 alteration may be a primary factor in ischemia-induced brain edema.
Recently, Manley et al., (14) using acute water intoxication and ischemic stroke experiments performed in normal and AQP4 KO mice to make AQP4-KD showed that AQP4 deletion is associated with greatly reduced cerebral edema. Thus, AQP4 deletion would lead to a slower accumulation of edema fluid in the brain, reducing acute brain swelling. These important findings suggest that AQP4 inhibition by pharmacological blockers might provide a new therapeutic alternative to current approaches (introduced more than 70 years ago) for the treatment of some forms of cerebral edema. Our experiments demonstrated that AQP4 inhibition by RNAi is specific and highly efficient in astrocyte primary cultures. Although it is unlikely that RNA interference could be used as an efficient drug to promptly block astrocyte swelling, AQP4 inhibition studies by RNAi in animals will be very useful to test the hypothesis that the inhibition of AQP4 activity is a potential target for the treatment of brain edema. Moreover, since AQP inhibitors are not at present available, RNAi might be developed into a highly efficacious tool to study the roles of AQP genes in organ physiology, thus providing an alternative to the use of KO animals.
In conclusion, the results presented in this paper indicate a direct involvement of AQP4 in physiological processes such as water transport and cell plasticity, as well as in the pathogenesis of brain edema. Furthermore, it is now possible to directly test the relationship between the function of AQP4 and ion movements involved in cell excitability such as K + and Cl -. Finally, AQP4 RNAi can be envisaged as an in vivo tool to study the molecular mechanism of brain edema. The levels of AQP4 protein bands of astrocytes treated with specific (AQP4 siRNA, black bar) and nonspecific (CTRL siRNA, gray bar) RNA duplexes were normalized to the untreated astrocytes (CTRL, white bar). B, top) AQP4 mRNA levels were documented by semi-quantitative RT-PCR experiments. Several controls (CTRL, untreated cells; Oligofect., oligofectamine-treated cells; CTRL siRNA, cells treated with control siRNA) were used to verify the specificity of the treatment. Arrow indicates a 410 bp AQP4 specific fragment co-amplified with a 18S RNA fragment (324 bp) indicated by the arrowhead, used as internal standard. B, bottom) Densitometric analysis of 3 independent semiquantitative RT-PCR experiments. The histogram shows AQP4 mRNA knockdown data as AQP4/rRNA ratio (*P<0.001). Bars: CTRL, white; Oligofect, striped; CTRL siRNA, gray; AQP4 siRNA, black. C) Time course of scattered light intensity in response to a sudden increase in extracellular osmolality from 300 to 550 mOsm. The osmotic gradient causes water efflux, astrocytes shrinkage, and an increase in scattered light intensity. AQP4 silencing determines a significant decrease in the rate of the cell volume changes. (red) and GFAP (green) expression at 2, 4, and 6 days after the treatment with CTRL siRNA and AQP4 siRNA. A weak diffuse AQP4 staining is observed after AQP4 post-translational gene silencing while no changes in GFAP expression level were found. Original magnification, x400. of the genes found altered at low stringency between AQP4-siRNA and CTRL astrocytes. In the chromatic scale, red indicates down-regulation and green up-regulation. B) At higher stringency, 5 ischemia-related genes were found to be significantly altered.
